NCT00994422

Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

A Double-Blind Randomized Study to Compare the Safety, Local Tolerability and Efficacy of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 264 (actual)
• Sponsor: Topaz Pharmaceuticals Inc · Industry
• Sex: All
• Age: 2 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the safety and efficacy of a 0.5% ivermectin cream to a placebo in subjects infested with head lice when used in an "at home" environment.

Conditions

• Head Lice

Interventions

Type	Name	Description
DRUG	Ivermectin cream	Up to 4 ounces of topical 0.5% Ivermectin Cream applied to the hair and scalp on day 1.
DRUG	vehicle control	Up to 4 ounces of vehicle control applied to the hair and scalp on day 1

Timeline

• Start date: 2009-10-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2009-10-14
• Last updated: 2012-04-06
• Results posted: 2012-04-04

Locations

12 sites across 1 country: United States